Related Experiment Video
Updated: Jun 26, 2026

09:21
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
Rhabdomyosarcoma Confined to the Bone Marrow: A Case Report and Literature Review
Mohammad Hassan Hodroj1, Chloe Batrouni2, Alexandre da Silva Faco Junior1
1Department of Medical Oncology, Cedars Cancer Centre, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
Current Oncology (Toronto, Ont.)
|June 25, 2026
Summary
Rhabdomyosarcoma (RMS) isolated in the bone marrow is rare and aggressive, mimicking leukemia. Intensive chemotherapy showed efficacy in a patient with this challenging presentation.
Area of Science:
- Oncology
- Hematology
- Pathology
Background:
- Rhabdomyosarcoma (RMS) confined to bone marrow is exceptionally rare and aggressive.
- It often mimics primary hematological malignancies, causing diagnostic delays.
Purpose of the Study:
- To report a case of bone marrow-confined alveolar RMS with PAX3/FOXO1 rearrangement.
- To review literature on diagnostic challenges and treatment strategies for this rare entity.
Main Methods:
- Comprehensive diagnostic work-up including immunohistochemistry and molecular studies.
- Literature review on bone-marrow-confined RMS.
- Treatment with intensive multi-agent chemotherapy.
Main Results:
- Diagnosis of PAX3/FOXO1 gene-rearranged alveolar RMS isolated in the bone marrow confirmed.
- Patient achieved hematological recovery and radiological improvement with chemotherapy.
- Literature review highlighted diagnostic pitfalls and treatment variability.
Conclusions:
- RMS confined to bone marrow presents diagnostic challenges due to atypical presentation.
- Intensive chemotherapy may be effective for this aggressive entity.
- Standardized management guidelines are lacking for bone-marrow-confined RMS.
More Related Videos
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

